Abbott Laboratories Stock Performance
ABT Stock | USD 113.66 0.18 0.16% |
Abbott Laboratories has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.81, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Abbott Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding Abbott Laboratories is expected to be smaller as well. Abbott Laboratories right now shows a risk of 1.12%. Please confirm Abbott Laboratories value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to decide if Abbott Laboratories will be following its price patterns.
Risk-Adjusted Performance
4 of 100
Low | High |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable fundamental drivers, Abbott Laboratories is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return 0.16 | Five Day Return 1.92 | Year To Date Return 3.47 | Ten Year Return 195.14 | All Time Return 22.6 K |
Forward Dividend Yield 0.0194 | Payout Ratio 0.4775 | Last Split Factor 10000:4798 | Forward Dividend Rate 2.2 | Dividend Date 2024-05-15 |
Abbott Laboratories dividend paid on 15th of February 2024 | 02/15/2024 |
1 | Jefferies bullsih on DexCom, highlights Stelo drug hype | 03/07/2024 |
2 | Deutsche Bank AG Sells 432,200 Shares of Abbott Laboratories | 03/11/2024 |
3 | Diabetes and Heart Disease How to Manage Your Risk | 03/15/2024 |
4 | Canadian First - Abbott Advances Chronic Pain Management with the Worlds Smallest Implanted, Rechargeable Spinal Cord Stimulation System | 03/19/2024 |
5 | Abbott Stock Slides as Market Rises Facts to Know Before You Trade | 03/20/2024 |
6 | 3 Resilient Stocks to Protect Your Wealth During a Recession | 03/21/2024 |
7 | Preterm Birth and PROM Testing Market 2024, Business Growing Strategies, Regional Growth by 2031 Abbott Laboratories | 03/22/2024 |
8 | Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member | 03/25/2024 |
9 | Abbott Increases Despite Market Slip Heres What You Need to Know | 03/26/2024 |
10 | Abbott signs executive order to curb antisemitism on Texas campuses, demands appropriate punishments | 03/28/2024 |
Begin Period Cash Flow | 9.9 B |
Abbott |
Abbott Laboratories Relative Risk vs. Return Landscape
If you would invest 10,932 in Abbott Laboratories on December 30, 2023 and sell it today you would earn a total of 434.00 from holding Abbott Laboratories or generate 3.97% return on investment over 90 days. Abbott Laboratories is generating 0.0701% of daily returns assuming volatility of 1.1226% on return distribution over 90 days investment horizon. In other words, 9% of stocks are less volatile than Abbott, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
Abbott Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abbott Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abbott Laboratories, and traders can use it to determine the average amount a Abbott Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0624
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | ABT | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.12 actual daily | 9 91% of assets are more volatile |
Expected Return
0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Abbott Laboratories is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abbott Laboratories by adding it to a well-diversified portfolio.
Abbott Laboratories Fundamentals Growth
Abbott Stock prices reflect investors' perceptions of the future prospects and financial health of Abbott Laboratories, and Abbott Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abbott Stock performance.
Return On Equity | 0.15 | ||||
Return On Asset | 0.0611 | ||||
Current Valuation | 205.26 B | ||||
Shares Outstanding | 1.74 B | ||||
Price To Earning | 24.14 X | ||||
Price To Book | 5.10 X | ||||
Price To Sales | 4.91 X | ||||
Revenue | 40.11 B | ||||
Gross Profit | 24.58 B | ||||
EBITDA | 9.68 B | ||||
Net Income | 5.7 B | ||||
Cash And Equivalents | 9.88 B | ||||
Cash Per Share | 5.68 X | ||||
Debt To Equity | 0.46 % | ||||
Current Ratio | 1.86 X | ||||
Cash Flow From Operations | 7.26 B | ||||
Earnings Per Share | 3.26 X | ||||
Total Asset | 73.21 B | ||||
Retained Earnings | 37.55 B | ||||
Current Asset | 14.15 B | ||||
About Abbott Laboratories Performance
To evaluate Abbott Laboratories Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Abbott Laboratories generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Abbott Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Abbott Laboratories market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Abbott's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for 2024 | ||
Return On Capital Employed | 0.11 | 0.10 | |
Return On Assets | 0.08 | 0.12 | |
Return On Equity | 0.15 | 0.26 |
Things to note about Abbott Laboratories performance evaluation
Checking the ongoing alerts about Abbott Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abbott Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Over 77.0% of the company shares are held by institutions such as insurance companies | |
On 15th of February 2024 Abbott Laboratories paid $ 0.55 per share dividend to its current shareholders | |
Latest headline from foxnews.com: Abbott signs executive order to curb antisemitism on Texas campuses, demands appropriate punishments |
- Analyzing Abbott Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abbott Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Abbott Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abbott Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abbott Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abbott Laboratories' stock. These opinions can provide insight into Abbott Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.55 | Dividend Share 2.08 | Earnings Share 3.26 | Revenue Per Share 23.051 | Quarterly Revenue Growth 0.015 |
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.